---
title: Comparison of recognition of symptom burden in MPN between patient- and physician-reported
  assessment - an intraindividual analysis by the German Study Group for MPN (GSG-MPN)
date: '2025-02-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40000843/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250226171103&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Myeloproliferative neoplasms (MPN) are associated with a variety of symptoms
  that severely impact patients' quality of life and ability to perform daily activities.
  Recent studies showed differences in the perception of physician- versus patient-reported
  symptom burden. However, studies directly comparing patient- and physician-reported
  ratings are lacking. Here, a retrospective analysis on symptom burden of 3979 MPN
  patients of the Bioregistry of the German Study Group for MPN was conducted ...
disable_comments: true
---
Myeloproliferative neoplasms (MPN) are associated with a variety of symptoms that severely impact patients' quality of life and ability to perform daily activities. Recent studies showed differences in the perception of physician- versus patient-reported symptom burden. However, studies directly comparing patient- and physician-reported ratings are lacking. Here, a retrospective analysis on symptom burden of 3979 MPN patients of the Bioregistry of the German Study Group for MPN was conducted ...